ACSS2 and inflammatory bowel disease: Inflammatory cytokines are known to contribute to IBD progression by reprogramming gene expression in intestinal epithelium.[42, 43, 44] To reveal the mechanism behind ACSS2 downregulation, we treated intestinal epithelial cells with a panel of inflammatory cytokines.